Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.58 |
| ▸ | NPY1R | P25929 | 7/20 | 0.58 |
| ▸ | NPY2R | P49146 | 5/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.58 |
| ▸ | FNTA | P49354 | 4/20 | 0.54 |
| ▸ | FNTB | P49356 | 4/20 | 0.54 |
| ▸ | PGGT1B | P53609 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30401277 | 0.93 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL30345344 | 0.92 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30844026 | 0.90 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29462004 | 0.90 | NPY4R (0.62) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL29541285 | 0.88 | NPY4R (0.69) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30957020 | 0.88 | FNTA (0.62) | FNTAFNTBPGGT1B | |
| SCHEMBL29619346 | 0.88 | FNTA (0.60) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL29450696 | 0.88 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30045696 | 0.87 | FNTA (0.59) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL29872147 | 0.87 | FNTA (0.59) | NPY4RNPY1RNPY2RNPY5RFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036858-A | Tuna blood source active peptide with ACE (angiotensin converting enzyme) inhibitory activity and application thereof | 三亚热带水产研究院 | 2026-05-15 | — | — | CN | disclosed |